Roche extends SMA market lead with Evrysdi tablet approval in Europe
Already offering the only non-invasive treatment for SMA in liquid form, Roche’s Evrysdi now comes as a tablet.
Already offering the only non-invasive treatment for SMA in liquid form, Roche’s Evrysdi now comes as a tablet.
What's Your Reaction?
